Techne Corporation Releases Unaudited Second Quarter Results for Fiscal... (ual report on Form 10-K and quarterly re...)

Techne Corporation Releases Unaudited Second Quarter Results for Fiscal Year 2008

Date:1/29/2008

ual report on Form 10-K and quarterly reports on Form 10-Q as filed with the Securities and Exchange Commission. We undertake no obligation to update or revise any forward-looking statements we make in this release due to new information or future events. Investors are cautioned not to place undue emphasis on these statements.

Techne Corporation has two operating subsidiaries: Research and Diagnostic Systems, Inc. (R&D Systems) of Minneapolis, Minnesota and R&D Systems Europe, Ltd. (R&D Europe) of Abingdon, England. R&D Systems is a specialty manufacturer of biological products. R&D Systems has two subsidiaries, BiosPacific, Inc. (BiosPacific), located in Emeryville, California and R&D Systems China Co. Ltd., (R&D China), located in Shanghai, China. BiosPacific is a worldwide supplier of biologics to manufacturers of in vitro diagnostic systems and immunodiagnostic kits. R&D China and R&D Europe distribute biotechnology products.

TECHNE CORPORATION

CONSOLIDATED STATEMENTS OF EARNINGS

(In thousands, except per share data)

(Unaudited)

QUARTER ENDED SIX MONTHS ENDED

12/31/07 12/31/06 12/31/07 12/31/06

Net sales $62,142 $52,509 $120,129 $104,860

Cost of sales 12,751 10,714 24,855 21,951

Gross margin 49,391 41,795 95,274 82,909

Operating expenses:

Selling, general and

administrative 10,645 8,830 18,735 15,897

Research and development 5,562 5,044 10,743 9,899

Amortization of intangible

assets 282 404 570 807

Total operating expenses 16,489 14,278 30,048 26,603

Operating inco
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6 7
Related biology technology :

1. Techne Corporation Announces Share Repurchase Authorization
2. China Bionanometer Industries Corporation Announces Record Second Quarter 2007 Results
3. Hagens Berman Sobol Shapiro: Lawsuit Filed Against CellCyte Genetics Corporation
4. Sigma-Aldrich Corporations 4th Quarter 2007 Earnings Conference Call
5. Omeros Corporation Files Registration Statement for Proposed Initial Public Offering
6. Genelex Corporation Defends Consumers Right to Obtain DNA Information:
7. Pharmos Corporation Completes Initial Closing of Private Placement
8. Pharmos Corporation Announces Board and Management Changes
9. Environmental Tectonics Corporation Announces Sale of Monoplace Hyperbaric Chambers
10. CuraGen Corporation Announces Appointment of Sean Cassidy as CFO
11. LifeCell Corporation Schedules 2008 Financial Guidance Release and Conference Call; January 7, 2008 at 10:00 A.M. Eastern

Post Your Comments:

Techne Corporation Releases Unaudited Second Quarter Results for Fiscal...(ual report on Form 10-K and quarterly re...)